Diabetes technology

Efficacy of intermittent short‐term use of a real‐time continuous glucose monitoring system in non‐insulin–treated patients with type 2 diabetes: A randomized controlled trial

Diabetes Obes MetabPublished Randomised controlled trial

Primary result · Change in HbA1cResult — go to the resultAdjusted difference −0.68 %

Authors' conclusion

In non-insulin-treated patients with T2D uncontrolled with OADs, intermittent short-term use of RT-CGM was an effective method for glucose control, especially in those performing SMBG frequently.

Study context

Population
Non-insulin-treated patients with T2D uncontrolled with oral antidiabetic drugs (OADs); baseline HbA1c 8.2% ± 0.5%48 completed
Participants
61 patients
Comparison
Intermittent short-term real-time continuous glucose monitoring (RT-CGM) vs control
Primary endpoint
Change in HbA1c
Follow-up
6 months
Methodological detailsmulticentre, prospective, All participants used blinded CGM for up to 6 days with education before randomization; RT-CGM additionally applied for 1 week in intervention groups
  • Multicentre
  • Prospective
  • All participants used blinded CGM for up to 6 days with education before randomization; RT-CGM additionally applied for 1 week in intervention groups

Primary result

As reported in the abstract

Adjusted difference

−0.68 %

P = 0.018

Further findings

OutcomeAdjusted difference (%)P value
Change in HbA1c · 3 monthsTreatment group 1 vs Control−0.60P = 0.044
Change in HbA1c · 3 monthsTreatment group 2 vs Control−0.64P = 0.014

HbA1c change by self-monitoring of blood glucose (SMBG) frequency (treatment groups) · 3 and 6 months

SMBG ≥1.5 times/day: significant HbA1c improvement at 3 and 6 months
SMBG <1.5 times/day: no significant improvement

Original publication

Efficacy of intermittent short‐term use of a real‐time continuous glucose monitoring system in non‐insulin–treated patients with type 2 diabetes: A randomized controlled trial. Diabetes Obes Metab. Published 23 September 2022. doi:10.1111/dom.14852

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.